Perspective Therapeutics, Inc. (CATX)
USD 1.94
(1.04%)
USD 1.94
(1.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -14.67 Million USD | -105.09% |
| 2021 | -7.15 Million USD | -124.37% |
| 2020 | -3.18 Million USD | 2.48% |
| 2019 | -3.26 Million USD | 32.6% |
| 2018 | -4.85 Million USD | 27.61% |
| 2017 | -6.7 Million USD | -8.73% |
| 2016 | -6.16 Million USD | -30.81% |
| 2015 | -4.71 Million USD | -27.97% |
| 2014 | -3.68 Million USD | 38.23% |
| 2013 | -5.95 Million USD | -54.52% |
| 2012 | -3.85 Million USD | -10.54% |
| 2011 | -3.48 Million USD | -22.75% |
| 2010 | -2.84 Million USD | 29.54% |
| 2009 | -4.03 Million USD | 34.52% |
| 2008 | -6.16 Million USD | 28.01% |
| 2007 | -8.55 Million USD | 10.91% |
| 2006 | -9.6 Million USD | -16.88% |
| 2005 | -8.21 Million USD | 0.0% |
| 2003 | 75.75 Thousand USD | 226.2% |
| 2002 | -60.02 Thousand USD | -1.6% |
| 2001 | -59.08 Thousand USD | -125.13% |
| 2000 | 235.11 Thousand USD | 458.13% |
| 1999 | -65.64 Thousand USD | -103.6% |
| 1998 | 1.82 Million USD | 1407.46% |
| 1997 | -139.54 Thousand USD | 67.25% |
| 1996 | -426.07 Thousand USD | 80.2% |
| 1995 | -2.15 Million USD | -129.14% |
| 1994 | -939.16 Thousand USD | -114.62% |
| 1993 | -437.59 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -10.35 Million USD | 6.75% |
| 2022 Q3 | -371 Thousand USD | 83.13% |
| 2022 Q1 | -3.92 Million USD | -95.13% |
| 2022 Q2 | -2.19 Million USD | 44.02% |
| 2022 FY | -14.67 Million USD | -105.09% |
| 2022 Q4 | -11.1 Million USD | -2893.53% |
| 2021 Q3 | -1.2 Million USD | 24.75% |
| 2021 Q1 | -2.24 Million USD | -111.4% |
| 2021 FY | -7.15 Million USD | -124.37% |
| 2021 Q4 | -2.01 Million USD | -66.78% |
| 2021 Q2 | -1.6 Million USD | 28.49% |
| 2020 Q3 | -745 Thousand USD | 14.17% |
| 2020 Q2 | -868 Thousand USD | -21.74% |
| 2020 Q1 | -713 Thousand USD | 39.98% |
| 2020 FY | -3.18 Million USD | 2.48% |
| 2020 Q4 | -1.06 Million USD | -42.42% |
| 2019 Q3 | -545 Thousand USD | 39.24% |
| 2019 FY | -3.26 Million USD | 32.6% |
| 2019 Q1 | -816 Thousand USD | 25.48% |
| 2019 Q2 | -897 Thousand USD | -9.93% |
| 2019 Q4 | -1.18 Million USD | -117.98% |
| 2018 Q1 | -1.5 Million USD | 36.05% |
| 2018 Q2 | -1.41 Million USD | 6.23% |
| 2018 Q3 | -1.12 Million USD | 20.3% |
| 2018 Q4 | -1.09 Million USD | 2.84% |
| 2018 FY | -4.85 Million USD | 27.61% |
| 2017 Q3 | -1.33 Million USD | 8.95% |
| 2017 FY | -6.7 Million USD | -8.73% |
| 2017 Q2 | -1.46 Million USD | 5.37% |
| 2017 Q1 | -1.54 Million USD | 16.61% |
| 2017 Q4 | -2.35 Million USD | -77.03% |
| 2016 Q1 | -1.49 Million USD | -26.43% |
| 2016 FY | -6.16 Million USD | -30.81% |
| 2016 Q4 | -1.85 Million USD | -36.32% |
| 2016 Q3 | -1.36 Million USD | 6.21% |
| 2016 Q2 | -1.45 Million USD | 3.2% |
| 2015 FY | -4.71 Million USD | -27.97% |
| 2015 Q4 | -1.18 Million USD | 0.88% |
| 2015 Q3 | -1.19 Million USD | 8.87% |
| 2015 Q2 | -1.31 Million USD | -28.7% |
| 2015 Q1 | -1.01 Million USD | 1.51% |
| 2014 Q2 | -906.95 Thousand USD | -15.41% |
| 2014 Q1 | -785.86 Thousand USD | 53.16% |
| 2014 Q4 | -1.03 Million USD | -8.51% |
| 2014 FY | -3.68 Million USD | 38.23% |
| 2014 Q3 | -953.55 Thousand USD | -5.14% |
| 2013 Q2 | -926.97 Thousand USD | 27.06% |
| 2013 FY | -5.95 Million USD | -54.52% |
| 2013 Q1 | -1.27 Million USD | -27.91% |
| 2013 Q4 | -1.67 Million USD | 19.47% |
| 2013 Q3 | -2.08 Million USD | -124.76% |
| 2012 Q1 | -993.66 Thousand USD | 17.54% |
| 2012 FY | -3.85 Million USD | -10.54% |
| 2012 Q3 | -715.03 Thousand USD | 38.06% |
| 2012 Q2 | -1.15 Million USD | -16.17% |
| 2012 Q4 | -993.56 Thousand USD | -38.95% |
| 2011 FY | -3.48 Million USD | -22.75% |
| 2011 Q3 | -552.88 Thousand USD | 12.07% |
| 2011 Q4 | -1.2 Million USD | -117.94% |
| 2011 Q1 | -1.1 Million USD | -54.81% |
| 2011 Q2 | -628.74 Thousand USD | 42.96% |
| 2010 Q1 | -871.88 Thousand USD | 19.42% |
| 2010 FY | -2.84 Million USD | 29.54% |
| 2010 Q2 | -228.06 Thousand USD | 73.84% |
| 2010 Q3 | -1.03 Million USD | -351.73% |
| 2010 Q4 | -711.99 Thousand USD | 30.89% |
| 2009 FY | -4.03 Million USD | 34.52% |
| 2009 Q1 | -906.7 Thousand USD | 27.69% |
| 2009 Q3 | -1.09 Million USD | -15.31% |
| 2009 Q4 | -1.08 Million USD | 1.21% |
| 2009 Q2 | -949.86 Thousand USD | -4.76% |
| 2008 Q2 | -1.63 Million USD | 8.95% |
| 2008 FY | -6.16 Million USD | 28.01% |
| 2008 Q1 | -1.79 Million USD | -24.43% |
| 2008 Q4 | -1.25 Million USD | 15.29% |
| 2008 Q3 | -1.48 Million USD | 9.36% |
| 2007 Q2 | -2.78 Million USD | -29.03% |
| 2007 Q1 | -2.15 Million USD | 21.05% |
| 2007 Q4 | -1.44 Million USD | 33.58% |
| 2007 FY | -8.55 Million USD | 10.91% |
| 2007 Q3 | -2.17 Million USD | 22.11% |
| 2006 Q4 | -2.73 Million USD | -35.13% |
| 2006 Q2 | -1.91 Million USD | 34.47% |
| 2006 Q1 | -2.92 Million USD | -11.76% |
| 2006 FY | -9.6 Million USD | -16.88% |
| 2006 Q3 | -2.02 Million USD | -5.51% |
| 2005 Q3 | -1.65 Million USD | 16.14% |
| 2005 Q2 | -1.97 Million USD | -1.0% |
| 2005 Q4 | -2.61 Million USD | -57.8% |
| 2005 FY | -8.21 Million USD | 0.0% |
| 2005 Q1 | -1.95 Million USD | 0.0% |
| 2004 Q2 | -3574.00 USD | 14.27% |
| 2004 Q3 | 302.04 Thousand USD | 8551.04% |
| 2004 Q1 | -4169.00 USD | -155.79% |
| 2003 Q2 | -5934.00 USD | 40.64% |
| 2003 FY | 75.75 Thousand USD | 226.2% |
| 2003 Q3 | -4593.00 USD | 22.6% |
| 2003 Q1 | -9996.00 USD | 27.54% |
| 2003 Q4 | 7472.00 USD | 262.68% |
| 2002 Q3 | -15.68 Thousand USD | 23.66% |
| 2002 FY | -60.02 Thousand USD | -1.6% |
| 2002 Q1 | -12.6 Thousand USD | 12.2% |
| 2002 Q2 | -20.54 Thousand USD | -63.04% |
| 2002 Q4 | -13.79 Thousand USD | 12.05% |
| 2001 Q2 | -14.37 Thousand USD | -105.0% |
| 2001 Q3 | -17.75 Thousand USD | -23.55% |
| 2001 Q4 | -14.35 Thousand USD | 19.14% |
| 2001 Q1 | 287.61 Thousand USD | 1312.27% |
| 2001 FY | -59.08 Thousand USD | -125.13% |
| 2000 Q4 | -23.72 Thousand USD | -71.3% |
| 2000 Q2 | -14.92 Thousand USD | 44.62% |
| 2000 Q1 | -26.95 Thousand USD | -109.03% |
| 2000 FY | 235.11 Thousand USD | 458.13% |
| 2000 Q3 | -13.85 Thousand USD | 7.23% |
| 1999 Q3 | -12.9 Thousand USD | -0.04% |
| 1999 FY | -65.64 Thousand USD | -103.6% |
| 1999 Q4 | -12.89 Thousand USD | 0.02% |
| 1999 Q1 | 1.83 Million USD | 11785.92% |
| 1999 Q2 | -12.89 Thousand USD | -100.7% |
| 1998 Q2 | 1.85 Million USD | 0.0% |
| 1998 Q3 | -14.53 Thousand USD | -100.78% |
| 1998 Q4 | -15.73 Thousand USD | -8.21% |
| 1998 FY | 1.82 Million USD | 1407.46% |
| 1997 FY | -139.54 Thousand USD | 67.25% |
| 1996 FY | -426.07 Thousand USD | 80.2% |
| 1995 FY | -2.15 Million USD | -129.14% |
| 1994 FY | -939.16 Thousand USD | -114.62% |
| 1993 FY | -437.59 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Electromed, Inc. | 5.15 Million USD | 384.854% |
| Senseonics Holdings, Inc. | -60.39 Million USD | 75.709% |
| Catheter Precision, Inc. | -70.57 Million USD | 79.213% |
| Xtant Medical Holdings, Inc. | 660 Thousand USD | 2322.727% |